Could a common diabetes drug help people with rectal cancer respond better to treatment?

When you're facing a diagnosis of locally advanced rectal cancer, the treatment path is intense: weeks of chemotherapy and radiation to shrink the tumor before surgery. This study asked a simple but important question: could adding a common, well-known diabetes pill make that pre-surgery treatment work better? The drug is called metformin. Doctors had noticed that people with diabetes who took metformin seemed to have better survival odds, and lab studies showed the drug could slow cancer cell growth. So, they designed a trial to test it in people with this specific cancer. In the study, patients took metformin pills alongside their standard pre-surgery chemo and radiation. The goal was to see if this combination led to what doctors call a 'complete pathological response'—meaning when the surgeon removed the tissue, no cancer cells could be found under the microscope. Finding no cancer cells after this intense treatment is a very good sign. The study enrolled 60 people to see if this accessible, repurposed drug could offer them a better chance.